Loading organizations...
K2 HealthVentures, a Boston, Massachusetts-based alternative investment firm, provides flexible, long-term debt and equity capital to private and public life sciences and healthcare companies. Specializing in venture and growth-stage financing, the firm operates with an evergreen fund structure, backed by L1 Health, with an initial $400 million capital commitment. Since its 2018 launch, K2 HealthVentures has committed over $2 billion in debt and equity across more than 50 transactions. Its leadership team, including Austin Sherwindt and Nimesh Shah, has a collective track record of deploying over $4 billion across more than 100 portfolio companies. A portion of profits funds underserved healthcare areas globally. With 21-50 employees, K2 HealthVentures was founded in 2018 by Parag Shah and Anup Arora. Its business model centers on earns returns through debt and equity investments in life sciences and healthcare companies, backed by permanent capital from L1 Health with no fixed fund cycles.
Key people at K2 HealthVentures.
K2 HealthVentures was founded in 2018 by Parag Shah (Founder, Managing Director & CEO) and Anup Arora (Founder, Managing Director & CIO).
K2 HealthVentures was founded in 2018 by Parag Shah (Founder, Managing Director & CEO) and Anup Arora (Founder, Managing Director & CIO).
K2 HealthVentures has 8 tracked investments across 8 companies. The latest tracked deal is $110.0M Series A in Zarminali Health in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 21, 2026 | Zarminali Health | $110.0M Series A | Amir DAN Rubin | Holly Maloney Mcconnell |
| Jan 11, 2026 | Apella Technology | $80.0M Series B | Corey Mulloy | Casdin Capital, Roberta Schwartz, Opamp Capital, Operator Partners, PFM Health Sciences, Upside Partnership, Vensana Capital |
| Jan 11, 2023 | 89bio | $100.0M Debt | K2 Healthventures | — |
| Jul 28, 2022 | Elevation Oncology | $50.0M Debt | K2 Healthventures | — |
| Oct 13, 2021 | Invaio Sciences | $50.0M Debt | K2 Healthventures | — |
| Sep 1, 2021 | Click Therapeutics | $52.0M Series B | URI Geiger, Alex Zisson | Eight Roads Ventures, Sanofi Ventures, Webtalk LTD, Health Catalyst Capital, Hikma Ventures, Revelation Partners, Ridgetop Health |
| Aug 6, 2021 | Cricket Health | $83.5M Series B | Tracy Bahl | Susan Fleischman, TOM Richards, OAK HC/FT |
| Jul 13, 2021 | ASLAN Pharmaceuticals | $45.0M Debt | K2 Healthventures | — |
